SCHEMBL7338228

SCHEMBL7338228

Cc1[nH]c(=O)[nH]c1C(=O)c1ccc(-n2cnc3ccccc32)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 8/20 1.00
▸ PDE4B Q07343 8/20 1.00
▸ PDE4C Q08493 8/20 1.00
▸ PDE4D Q08499 8/20 1.00
▸ FGFR1 P11362 3/20 0.56
▸ PDE3B Q13370 2/20 0.48
▸ PDE3A Q14432 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ PMP22 Q01453 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ HTT P42858 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7340234 0.76 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7383547 0.76 FGFR1 (0.72) PDE4APDE4BPDE4CPDE4DFGFR1
SCHEMBL10918080 0.74 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DFGFR1
SCHEMBL7341617 0.74 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL1816262 0.74 FGFR1 (0.70) PDE4APDE4BPDE4CPDE4DFGFR1
Hydrochloric Acid SCHEMBL10370157 0.74 PDE4A (0.95) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7339717 0.73 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL20604030 0.73 FGFR1 (0.74) PDE4APDE4BPDE4CPDE4DFGFR1
SCHEMBL29993159 0.73 FGFR1 (0.74) PDE4APDE4BPDE4CPDE4DFGFR1
SCHEMBL1812955 0.72 FGFR1 (1.00) PDE4APDE4BPDE4CPDE4DFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0169164-A1 Imidazolonecarbonylarylimidazoles; method of manufacture, method of use and compositions useful thereof SCHERING AKTIENGESELLSCHAFT (DE) 1986-01-22 — — EP claimed
US-4556665-A Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones SCHERING A.G. (DE) 1985-12-03 — — US claimed
EP-0169164-B1 IMIDAZOLONECARBONYLARYLIMIDAZOLES; METHOD OF MANUFACTURE, METHOD OF USE AND COMPOSITIONS USEFUL THEREOF SCHERING AKTIENGESELLSCHAFT (DE) 1990-01-31 — — EP disclosed
US-4709043-A Process for the preparation of imidazolonecarbonylarylimidazoles SCHERING A.G. (DE) 1987-11-24 — — US disclosed
EP-0169164-A1 Imidazolonecarbonylarylimidazoles; method of manufacture, method of use and compositions useful thereof SCHERING AKTIENGESELLSCHAFT (DE) 1986-01-22 — — EP disclosed
US-4556665-A Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones SCHERING A.G. (DE) 1985-12-03 — — US disclosed
Send feedback